What is Bioventus's net change in cash?

Bioventus (BVS) reported net change in cash of -$15.39M in Q1 2026.

How has Bioventus's net change in cash changed year-over-year?

Bioventus's net change in cash increased by 18.0% year-over-year, from -$18.78M to -$15.39M.

What is the long-term trend for Bioventus's net change in cash?

Over 2 years (2022 to 2025), Bioventus's net change in cash has grown at a -62.1% compound annual growth rate (CAGR), from -$67.38M to $9.66M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Bioventus BVS Net Change in Cash

Net Change in Cash at other companies

StrykerSYK

-$1.13B+14.9%

Orthofix Medical Inc.OFIX

$35.76M+241%

Zimmer Biomet HoldingsZBH

-$167.7M-120%

MedtronicMDT

-$136M+11.7%

Globus MedicalGMED

$34.79M+111%

Organogenesis Holdings Inc.ORGO

-$2.23M+91.3%

Other financials

Income statement

See full

Revenue$132.1M+6.6%

Gross profit$90.8M+9.3%

Operating income$8.4M+72.8%

Net income$3.1M+218%

EPS (diluted)$0.04+200%

Balance sheet

See full

Cash & equivalents$35.8M+57.2%

Total debt$288.4M-21.2%

Total equity$188.9M+27.5%

Total assets$650.5M-5.9%

Cash flow

See full

Operating cash flow$8.9M+146%

CapEx$574.0K-30.5%

Free cash flow$8.4M+141%

Valuation

See full

Market cap$659.19M+51.7%

Enterprise value$911.76M+17.2%

P/E23.1×—

P/S1.1×+0.4×

Profitability

See full

Gross margin68.7%+1.2pp

Operating margin10%—

Net margin4.9%+3.2pp

FCF margin17.5%+13.2pp

Returns & leverage

See full

Return on equity16.9%+10.9pp

Debt / equity1.5×-0.9×

Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bioventus's net change in cash?: Bioventus (BVS) reported net change in cash of -$15.39M in Q1 2026.
How has Bioventus's net change in cash changed year-over-year?: Bioventus's net change in cash increased by 18.0% year-over-year, from -$18.78M to -$15.39M.
What is the long-term trend for Bioventus's net change in cash?: Over 2 years (2022 to 2025), Bioventus's net change in cash has grown at a -62.1% compound annual growth rate (CAGR), from -$67.38M to $9.66M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.